Loading stock data…
$0.77-0.05 (-5.81%)
Creative Medical Technology Holdings, Inc., a commercial-stage biotechnology company, focuses on novel biological therapeutics in the fields of immunotherapy, endocrinology, urology, neurology, and orthopedics in the United States.
Creative Medical Technology Holdings, Inc. in the Healthcare sector is trading at $0.77 with a market capitalization of $6M. Wall Street consensus targets $20.00 (1 analysts), implying a +2489.7% move over the next 12 months. The stock is currently near its 52-week low of $0.62, remaining 53.5% below its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality, Altman Z in the distress zone. Risk note: RSI 22 is oversold, raising the odds of a near-term bounce; MACD remains below its signal line. The Whystock Score of 50/100 suggests a balanced risk-reward profile.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $0 | $0↓ | $3,000 | $0 | $0 |
| Gross Profit | $0 | $0↓ | $2,006 | $0 | $0 |
| Operating Income | -$1.56M↓ | -$1.46M↑ | -$1.95M↓ | -$1.27M↓ | -$1.26M |
| Net Income | -$1.51M↓ | -$1.41M↑ | -$1.89M↓ | -$1.24M↓ | -$1.23M |
Creative Medical Technology Holdings, Inc., a commercial-stage biotechnology company, focuses on novel biological therapeutics in the fields of immunotherapy, endocrinology, urology, neurology, and orthopedics in the United States. The company offers...